NovoCure Ltd
NVCR
Market Cap$1.97B
Close$
$-5.24
129.6% downside
Current Fair Value
129.6% downsideOvervalued by 129.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.97 Billion |
|---|---|
| Enterprise Value | $2.06 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.56 |
| Beta | 0.75 |
| Outstanding Shares | 110,281,832 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.9 |
|---|---|
| PEG | 103.82 |
| Price to Sales | 3.54 |
| Price to Book Ratio | -8.86 |
| Enterprise Value to Revenue | 3.32 |
| Enterprise Value to EBIT | -17.61 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.25 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About NovoCure Ltd
CEO: Asaf Danziger